Exercise Training in Older Diabetic Women
The Effects of an Exercise and Diet Intervention on Cardiovascular Risk Factors in Postmenopausal Type 2 Diabetics
1 other identifier
interventional
35
1 country
1
Brief Summary
Type 2 diabetics (non-insulin-dependent) are more than five times as likely to suffer an initial myocardial infarction (MI; heart attack) compared to nondiabetics.Female diabetics in particular, have a higher mortality rate for coronary artery disease (CAD) than male diabetics.C-reactive protein measurement in the clinical setting enhances the detection of individuals who are at high risk for cardiovascular disease (CVD), by providing additional predictive value. We propose to study the effects of a supervised exercise and diet intervention on cardiovascular disease risk in postmenopausal diabetic women. We will recruit 35 postmenopausal, sedentary type 2 diabetics who will undergo a 3 month exercise and dietary intervention. They will exercise 3 times a week for 30 min in a supervised setting. Exercise mode will be aerobic and self-selected (i.e. treadmill, bike) at an intensity level of 50-85% VO2peak. Blood glucose will be monitored before and after exercise. The dietary intervention will consist of 6 meetings with a registered dietitian. The study is designed to test the following hypotheses:
- Cardiovascular disease risk measures will be different following a 3-month exercise and diet intervention.
- H1: Blood markers for coronary artery disease risk, as measured by CRP, TC, LDL, TG, FG, fasting insulin, and HbA1c, will be different following a 3-month exercise and diet intervention.
- H2: Anthropometric measures of coronary artery disease risk, as measured by WHR, will be different following a 3-month exercise and diet intervention.
- H3: Resting blood pressure, as measured by SBP and DBP, will be different following a 3-month exercise and diet intervention.
- H4: Total body fat, as measured by DXA, will be different following a 3-month exercise and diet intervention.
- Health-related measures will be different following a 3-month exercise and diet intervention.
- H1: Cardiorespiratory fitness, as measured by maximal oxygen consumption (VO2max) will be different following a 3-month exercise and diet intervention.
- H2: Bone-mineral density, as measured by DXA, will be different following a 3-month exercise and diet intervention.
- H3: Dietary measures (total daily kcal, and daily fat kcal) will be different following a 3-month exercise and diet intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 cardiovascular-diseases
Started Jun 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 19, 2006
CompletedFirst Posted
Study publicly available on registry
June 21, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedAugust 16, 2007
August 1, 2007
June 19, 2006
August 14, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
VO2max at 3 months
3 months
C-reactive protein at 3 months
3 months
Blood lipids (total cholesterol, LDL, HDL, TC/HDL ratio, triglycerides) at 3 months
3 months
Fasting glucose at 3 months
3 months
Fasting insulin (insulin resistance) at 3 months
3 months
HbA1C at 3 months
3 months
Body fat % at 3 months
3 months
Blood pressure (SBP, DBP) at 3 months
3 months
Waist-hip ratio at 3 months
3 months
Total kcal and fat kcal at 3 months
3 months
Secondary Outcomes (1)
Bone-mineral density at 3 months
3 months
Interventions
Eligibility Criteria
You may qualify if:
- Female 45-75 yrs old
- Type 2 diabetic for \> 6 months
- "Reasonable" control of diabetes
- blood glucose within 100-250 mg/dl prior to exercise
- absence of hypoglycemic symptoms
- diabetes control verified by physician
- cleared by physician to begin exercise program
- Postmenopausal \> 6 months
- Sedentary
- Ability and willingness of patient to give written, informed consent
- Able and willing to participate in an exercise intervention
You may not qualify if:
- Diabetes not in control
- unable to maintain blood glucose within 100-250 mg/dl
- development of urinary ketone bodies (ketosis)
- symptoms of hypoglycemia before, during, and post-exercise
- no physician's approval to participate
- Male
- Female \<45 or \>75 yr
- \> 300 lb (weight limit for DXA table)
- On insulin
- Contraindications to Exercise Testing (ACSM, 2000)
- Ischemia
- Recent myocardial infarction
- Unstable angina
- Uncontrolled cardiac arrhythmias
- Severe aortic stenosis
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Sellmeyer, M.D.
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
June 1, 2006
Study Completion
May 1, 2007
Last Updated
August 16, 2007
Record last verified: 2007-08